Ombitasvir, paritaprevir, ritonavir and dasabuvir and Tinzaparin Subcutaneous
Determining the interaction of Ombitasvir, paritaprevir, ritonavir and dasabuvir and Tinzaparin Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets, and Dasabuvir
Generic Name: tinzaparin
Brand name:
Synonyms: Tinzaparin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Tiotropium
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Tiotropium and Olodaterol
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Tiotropium and olodaterol Inhalation
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Tiotropium Bromide
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Tiotropium Capsules for Inhalation
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Tiotropium inhalation
- Tinzaparin Subcutaneous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Tinzaparin Subcutaneous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Tinzaparin Subcutaneous-Omeclamox-Pak
- Tinzaparin Subcutaneous-Omega-3 Fatty Acid Capsules
- Tinzaparin Subcutaneous-Omega-3 Fatty Acids
- Tinzaparin Subcutaneous-Omega-3 polyunsaturated fatty acids